Viewing nowCombinationDapljin Met Extended-release Tablet 10/1000 mg
Dapagliflozin Propanediol Hydrate 12.3mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Dongkuk Pharmaceutical Co., Ltd.

MFDS item code 202300353 · Approved 2023.01.27 · Insurance code 653405290
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used in combination with dapagliflozin and metformin as an adjunct to dietary and exercise therapy to help control blood sugar levels in adults with type 2 diabetes. In particular, in patients with type 2 diabetes who have poor blood sugar control and have cardiovascular disease or risk factors, further information from a specialist regarding the impact of dapagliflozin on cardiovascular events should be referred to. This medication is used to improve blood sugar control in patients with type 2 diabetes.
The dose of this medicine should be individualized based on the patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg. This medicine is generally administered once daily with the evening meal. The maximum dose of this medicine is dapagliflozin 10mg/extended-release metformin 2000mg once daily, administered as 2 tablets of 5mg/1000mg. Patients with no prior antidiabetic drug treatment for whom adequate glycemic control is difficult to achieve with monotherapy: When used as initial therapy in patients with no prior antidiabetic drug treatment, the recommended starting dose of this medicine is 1 tablet of 5mg/500mg or 10mg/500mg once daily. The dose should be increased gradually to reduce gastrointestinal adverse reactions associated with metformin. In patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily. The dose of this medicine should provide the patient’s current dose of metformin or the nearest appropriate therapeutically equivalent dose. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted as appropriate. For patients switching from combination therapy with dapagliflozin and metformin to this medicine, treatment may be started at the doses of dapagliflozin and metformin they were previously receiving. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted as appropriate. When this medicine is used in combination with insulin or an insulin secretagogue, such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other antihyperglycemic agents. Because changes may cause alterations in glycemic control, any change in treatment for patients with type 2 diabetes should be made under close monitoring. This medicine must be swallowed whole and must never be crushed, cut, or chewed. Occasionally, inactive ingredients in this medicine may be excreted in the stool as a soft, hydrated mass resembling a tablet. Renal impairment No dose adjustment is required in patients with mild renal impairment. In patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or more and less than 60 mL/min/1.73 m2 who have no other condition that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this medicine, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this medicine is not recommended in patients with an eGFR below 45 mL/min/1.73m2. If the estimated glomerular filtration rate (eGFR) decreases to below 45 mL/min/1.73m2, this medicine must be discontinued immediately. Renal function should be assessed every 3~6 months. Older adults Because metformin is excreted by the kidneys and renal function is more likely to be reduced in older adults, this medicine should be used with caution as age increases (see Precautions for Use, 9. Administration to Older Adults, Patient section).
This medication can rarely cause a serious condition known as lactic acidosis; therefore, if any unusual symptoms occur during treatment, consult a physician immediately. There is a risk of hypoglycemia when this medication is used with other diabetes treatments, so caution is required. Patients with poor kidney function, dehydration, severe infections, acute myocardial infarction, or any condition that may affect kidney function should not take this medication. Pregnant or breastfeeding women should not use this medication, and patients with genetic issues such as lactose intolerance should also avoid it. This medication should be administered cautiously to patients with decreased fluid volume or impaired kidney function, and renal function and blood pressure should be regularly monitored before and during treatment. Adverse reactions such as genital infections, urinary tract infections, hypoglycemia, reduced fluid volume, ketoacidosis, and others may occur, so symptoms should be reported to a physician immediately. Vitamin B12 levels may decrease, so regular blood tests are recommended if used for an extended period. Alcohol consumption may increase the risk of adverse reactions from this medication, so avoid excessive drinking during treatment. This medication may interact with other drugs; therefore, inform your physician or pharmacist about any other medications you are taking. Elderly patients often have decreased kidney function, so careful dose adjustment and regular monitoring of kidney function are needed while using this medication. In the case of overdose, seek immediate medical attention; dialysis treatment may be required as necessary. This medication does not significantly affect driving or operating machinery, but caution is necessary as dizziness may occur. Always keep this medication out of reach of children and store it in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, it is advisable to store it at room temperature between 1 and 30 degrees Celsius to maintain its effectiveness.
Yellow, oval, double convex extended-release film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin Propanediol Hydrate 12.3mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Dongkuk Pharmaceutical Co., Ltd.
Metformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
Metformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
YouYoung Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Yuyoung Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.